Lyterian Therapeutics · 2 months ago
Executive Assistant/Office Manager
Lyterian Therapeutics is a biotech startup focused on developing medicines for patients in need. The Executive Assistant/Office Manager will oversee daily office activities, manage the CEO's calendar, coordinate meetings, assist with recruitment, and implement processes to support the company's growth.
BiotechnologyLife ScienceMedical
Responsibilities
Oversee the daily activities of the office
Strategically manage the CEO’s calendar and coordinate team meetings
Assist to arrange travel and process expenses for the team
Coordinate company events that foster connectivity and build community
Assist with recruitment and new hire onboarding processes
Help to build the team by coordinating interview schedules and being a warm point of contact for candidates
Research and implement new technological resources to optimize office processes and enhance productivity
Implement miscellaneous business processes, procedures, templates, and systems to support Lyterian through rapid growth
Assist with special projects
Qualification
Required
BS/BA with 5+ years of experience in operations, office management, project management, and/or administration
Strong skills in Microsoft Suite, including Teams, Excel, PowerPoint, SharePoint, and Word
Experience leading and/or holding broad operational roles to support the growth and maturity of a startup company
Self-motivated, pragmatic, proactive, and able to multitask
Strong managerial qualities, attention to detail, and organizational skills
Ability to build open and collaborative relationships
Ability to handle time-sensitive, confidential information with discretion and integrity
Initiative and boldness to dive into a fast-paced new startup
Preferred
Experience in biotech is a plus
Benefits
Annual bonus
Significant equity
Generous benefits package including comprehensive health, dental, and vision insurance for our employees and their families
401K match
Company
Lyterian Therapeutics
Lyterian Therapeutics focused on developing new drugs for diseases by using natural mechanisms of protein regulation.
Funding
Current Stage
Early StageRecent News
2025-04-16
Company data provided by crunchbase